Architects of Sovereign
Biotechnology.
A multidisciplinary assembly of physician-scientists, computational biologists, surgeons, and sovereign healthcare leaders translating discovery into population-scale therapies.
Translational Vision & Institutional Governance
The Executive Leadership Team guides GenRey's scientific vision, operational execution, strategic partnerships, commercialization pathways, and long-term institutional growth.
Dr. Jerry Lorren Dominic, MD
Co-Founder, President & Chief Executive Officer
“GenRey was founded on a singular conviction: that regenerative medicine cannot remain isolated in academic laboratories. We are building the sovereign infrastructure to translate breakthrough biology directly into population-scale human health.”
Dr. Dominic leads GenRey's corporate trajectory, unifying international scientific alliances, sovereign healthcare capital, and commercialization pathways. His leadership anchors the platform's US-GCC corridor, ensuring scientific discoveries progress rapidly through clinical validation to deployment.
Mohammad Yasar Qureshi
Co-Founder & Chief Operating Officer
“Operational excellence and cGMP-grade manufacturing infrastructure are the bridges between scientific discovery and patient access. We are architecting global supply chains for the future of life sciences.”
Mr. Qureshi directs GenRey's global operational infrastructure, overseeing facility engineering, regulatory compliance, cGMP manufacturing deployment, and regional execution across US and GCC jurisdictions.
Dr. Sudheer Kumar Ravuri, PhD
Chief Scientific Officer & Founding Scientific Advisor — Chairman, Board of Directors
“By integrating omics, computational biology, and cellular repair protocols into a single pipeline, GenRey is advancing from symptomatic treatment to true tissue rejuvenation.”
Dr. Ravuri leads GenRey's global scientific vision and translational medicine strategy. As Chairman of the Board of Directors, he governs scientific advisory protocols, peer-reviewed clinical validation, and the development of next-generation regenerative therapeutics.
World-Class Clinical & Research Guidance
Guided by distinguished physician-scientists, clinical researchers, and biotechnology operators across surgical systems, tissue engineering, and translational omics.
Dr. Daniel A. Romanelli, MD
Senior Advisor — Regenerative Medicine
Advisory guidance across clinical strategy, regenerative medicine, and healthcare industry relations.
Dr. Moses Raj, MD
Scientific Advisory Committee Member
Advisory guidance across regenerative medicine, clinical development, and cellular therapy standards.
Dr. Aaron H. Wolfson, MD
Scientific Advisory Committee Member
Advisory guidance across innovation, biotechnology hardware, and medical device delivery integration.
Dr. Patricia Byers, MD
Scientific Advisory Committee Member
Advisory guidance across clinical development, surgical protocols, and platform safety governance.
Dr. Asim Elahi, MD
Scientific Advisory Committee Member
Advisory guidance across clinical strategy, biotechnology innovation, and platform deployment.
Translational Task Forces Driving Execution
GenRey's Program Directors support the development, coordination, and advancement of key scientific, clinical, and operational programs across the platform.
Dr. Kaushik Sreerama Reddy, MBBS
Program Management Officer
Program coordination, operational management, and cross-functional platform execution.
Dr. Matthew Witkin, MD
Program Director
Oncology research and scientific strategy advancing GenRey's clinical translation programs.
Dr. Adam Bender-Heine, MD
Program Director
Head and neck surgery, facial reconstruction, and regenerative biotechnology translation.
Dr. Paul Anthony Berry, MD
Program Director
Program coordination and scientific strategy advancing GenRey's platform execution.
Dr. Mohammad Waqas Khan, MD
Program Director
Program coordination and scientific strategy advancing GenRey's platform execution.
Dr. Bindiya Sachdev, PhD
Program Director
Program coordination and scientific strategy advancing GenRey's platform execution.
Dr. Samreen Fatima, MBBS
Associate Director, Novel Drug Discovery & Machine Leraning Therapeutic Innovation
Driving strategic initiatives and operational excellence across GenRey's global ecosystem.
Dr. Eevee Zhou, MD
Program Director
Program coordination and scientific strategy advancing GenRey's platform execution.
Dr. Lubna Mohammed, MBBS, PPCR
Scientist, Translational Medicine & Strategic Research Programs
Driving strategic initiatives and operational excellence across GenRey's global ecosystem.
Dr. Anita Sarah Varghese, MD
Program Director
Driving strategic initiatives and operational excellence across GenRey's global ecosystem.
Dr. Jeffrey James Skubic, DO
Program Director
Driving strategic initiatives and operational excellence across GenRey's global ecosystem.
Dr. Sarah Khalil, MD
Physician | Translational Medicine,Clinical Research & Evidence-Based Healthcare
Driving strategic initiatives and operational excellence across GenRey's global ecosystem.
Board Leadership
Manages the board of directors and executive operations.
Jameel Khan
Lead Director, Board of Directors
Driving strategic initiatives and operational excellence across GenRey's global ecosystem.
Ahmad AlQallaf
Lead Director, Board of Directors
Driving strategic initiatives and operational excellence across GenRey's global ecosystem.
Digital & IT Operations
Manages the organization's digital infrastructure and online presence. This role oversees website performance, manages IT systems and solutions, and drives digital engagement through strategic social media communication.
Er. Mintu Simson, B.E CSE
Digital Communications Lead
Manages the organization's digital infrastructure and online presence.
Connecting Academic Discovery to Sovereign Scale
GenRey's scientific talent architecture connects elite academic research institutions in the United States directly to GCC sovereign healthcare infrastructure.
Academic & Research Foundations
Our clinical leaders and advisors hail from world-leading medical institutions, bringing decades of peer-reviewed research, NIH grants, and intellectual property development.
- Basic Science & Omics IP Generation
- Early Phase Clinical Protocols
- Academic Medical Center Partnerships
Domestic Capability & Scale
Establishing regional cGMP bioreactor production, domestic workforce development, and clinical research fellowship programs aligned with GCC national healthcare mandates.
- Domestic Intellectual Property Co-Ownership
- cGMP Manufacturing Infrastructure
- Sovereign Health System Integration
Advancing the frontier of human longevity requires
extraordinary minds.
GenRey is actively recruiting physician-scientists, computational biologists, micro-fluidic engineers, and clinical operators passionate about sovereign-scale regenerative systems.
Member Name
Member Role
BIOGRAPHY & SCIENTIFIC FOCUS
Full biography text...